Literature DB >> 23625341

Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies.

Antonino Uncini1, Francesca Notturno, Margherita Capasso.   

Abstract

Natura non facit saltus (Latin for "nature does not make jumps") is a maxim expressing the idea that natural things and properties change gradually, in a continuum, rather than suddenly. In biomedical sciences, for taxonomic purposes, we make jumps that emphasize differences more than similarities. Among the dysimmune neuropathies, 2 disorders, characterized by the presence of antibodies to gangliosides GM1 and GD1a and a peculiar, exclusive motor involvement, have been identified: acute motor axonal neuropathy (AMAN) and multifocal motor neuropathy (MMN). However, anti-GM1 or -GD1a antibodies are also associated with acute motor and sensory axonal motor neuropathy (AMSAN). We review the results of recent clinical and experimental studies showing that AMAN and MMN are not exclusively motor. We discuss the possible explanations for the greater resistance of sensory fibers to antibody attack to finally suggest that AMAN, AMSAN, and MMN belong to a continuous spectrum with a common pathophysiological mechanism.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute motor and sensory axonal neuropathy; acute motor axonal neuropathy; anti-ganglioside antibodies; multifocal motor neuropathy; nodes of Ranvier

Mesh:

Substances:

Year:  2013        PMID: 23625341     DOI: 10.1002/mus.23881

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Multifocal motor neuropathy occurring after acute motor axonal neuropathy: two stages of the same disease?

Authors:  Silvia Bocci; Fabio Giannini; Nila Volpi; Alessandro Rossi; Federica Ginanneschi
Journal:  Neurol Sci       Date:  2021-11-20       Impact factor: 3.307

2.  Complement activity is associated with disease severity in multifocal motor neuropathy.

Authors:  Lotte Vlam; Elisabeth A Cats; Oliver Harschnitz; Marc D Jansen; Sanne Piepers; Jan Herman Veldink; Hessel Franssen; Abraham C J Stork; Erik Heezius; Suzan H M Rooijakkers; Bjorn L Herpers; Jos A van Strijp; Leonard H van den Berg; W Ludo van der Pol
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-06-25

Review 3.  Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.

Authors:  Melvin Berger; Jeffrey A Allen
Journal:  Muscle Nerve       Date:  2015-01-29       Impact factor: 3.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.